Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
VERBIO Vereinigte BioEnergie AG

Start price
Target price
Perf. (%)
€62.45
24.02.22
€70.00
24.02.23
-22.85%
25.02.23

Could be worthwhile Investment >10% per year
buy
Aixtron SE

Start price
Target price
Perf. (%)
€16.40
24.02.22
€20.00
24.02.23
53.35%
25.02.23

Could be worthwhile Investment >10% per year
buy
Eco Atlantic Oil and Gas Ltd

Start price
Target price
Perf. (%)
€0.37
24.02.22
-
24.02.23
-36.56%
25.02.23

buy
DBAG Deutsche Beteiligungs AG

Start price
Target price
Perf. (%)
€34.70
23.02.22
-
23.02.23
-13.40%
24.02.23

buy
Medigene AG

Start price
Target price
Perf. (%)
€3.79
22.02.22
€4.00
22.02.23
-45.05%
23.02.23

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€1.03
22.02.22
€1.00
22.02.23
-25.24%
05.03.22

Could be worthwhile Investment >10% per year
Capable Management
Bad culture
buy
Medigene AG

Start price
Target price
Perf. (%)
€3.71
22.02.22
€5.00
22.02.23
18.89%
23.02.22

Could be very worthwhile Investment >20% year
Very capable Management
Good culture
Little innovation
buy
Klöckner & Co SE

Start price
Target price
Perf. (%)
€10.58
22.02.22
€12.00
22.02.23
17.96%
01.03.22

Could be very worthwhile Investment >20% year
Higher EBIT margin than peer group
Very capable Management
Very good company culture
buy
GlobalTrans Investment GDR

Start price
Target price
Perf. (%)
€5.45
22.02.22
-
22.02.24
-63.30%
22.02.24

Could be worthwhile Investment >10% per year
buy
MBB SE

Start price
Target price
Perf. (%)
€120.60
21.02.22
€130.00
21.02.23
-10.78%
05.03.22

Standard Investments for future growth
Differentiated customer and product portfolio
Higher risks for its business
Significant cyclical dependencies
buy
Psi AG

Start price
Target price
Perf. (%)
€33.50
21.02.22
€40.00
21.02.23
-2.69%
05.03.22

Standard Investments for future growth
Innovative
Future proof or reliable business model
Significant cyclical dependencies
Global Fashion Group SA

Start price
Target price
Perf. (%)
€2.95
21.02.22
-
21.02.25
-92.19%
11.03.24

Probably not worthwhile Investment
Medigene AG

Start price
Target price
Perf. (%)
€2.91
21.02.22
-
21.02.29
-48.45%
11.03.24

Probably not worthwhile Investment
Novavax Inc.

Start price
Target price
Perf. (%)
€65.99
21.02.22
-
21.01.26
-92.38%
11.03.24

Probably not worthwhile Investment
buy
Aclaris Therapeutics Inc

Start price
Target price
Perf. (%)
€11.54
21.02.22
€15.00
21.02.23
2.90%
22.02.23

Could be worthwhile Investment >10% per year
Tokyo Electric Power

Start price
Target price
Perf. (%)
€2.77
21.02.22
€2.00
21.02.23
0.00%
25.02.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Nel ASA

Start price
Target price
Perf. (%)
€1.17
21.02.22
€2.50
21.02.23
6.02%
24.02.22

Future proof or reliable business model
Innovative
Valuable balance sheet
ROE higher than 10% per year
VERBIO Vereinigte BioEnergie AG

Start price
Target price
Perf. (%)
€58.05
21.02.22
€75.00
21.02.23
-5.17%
22.02.22

Well known brand
Market Leader or Top 3
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Bed Bath & Beyond Inc.

Start price
Target price
Perf. (%)
€13.13
21.02.22
€25.00
21.02.23
-7.07%
23.02.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
buy
Einhell Germany VZO

Start price
Target price
Perf. (%)
€192.00
21.02.22
-
21.02.23
-11.15%
22.02.23

First Majestic Silver Corp.

Start price
Target price
Perf. (%)
€10.10
21.02.22
-
21.02.23
-35.47%
22.02.23

Could be very worthwhile Investment >20% year
buy
Evofem Biosciences Inc.

Start price
Target price
Perf. (%)
€6.20
21.02.22
€13.50
21.02.23
2.90%
07.03.22

Could be very worthwhile Investment >20% year
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.015
20.02.22
€7.50
20.03.22
61900.00%
21.03.22

Could be worthwhile Investment >10% per year
buy
Chesapeake Gold Corp.

Start price
Target price
Perf. (%)
€2.10
20.02.22
-
20.02.23
-30.95%
22.10.22

Could be worthwhile Investment >10% per year
Capable Management
Innovative
Some uniques
buy
Myovant Sciences Ltd

Start price
Target price
Perf. (%)
€11.05
20.02.22
-
20.02.23
-1.99%
05.03.22

Could be very worthwhile Investment >20% year